Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-16 4:21 pm Purchase | 2026-03-09 | 13G | AN2 THERAPEUTICS INC ANTX | COMMODORE CAPITAL LP | 3,697,435 9.900% | 3,697,435 (New Position) | Filing History |
| 2026-03-13 5:02 pm Purchase | 2026-03-06 | 13G | AN2 THERAPEUTICS INC ANTX | INTEGRATED CORE STRATEGIES (US) LLC | 2,237,102 6.300% | 2,237,102 (New Position) | Filing History |
| 2026-03-13 4:02 pm Purchase | 2026-03-10 | 13G | AN2 THERAPEUTICS INC ANTX | Vivo Opportunity Fund Holdings L.P. | 2,864,346 8.000% | 2,864,346 (New Position) | Filing History |
| 2026-02-17 6:54 pm Purchase | 2025-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | Almitas Capital LLC | 2,975,164 5.400% | 1,546,841 (+108.30%) | Filing History |
| 2026-02-13 4:30 pm Purchase | 2025-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | Easom Eric | 2,232,004 7.900% | 338,872 (+17.90%) | Filing History |
| 2025-11-14 7:51 pm Purchase | 2025-09-30 | 13G | AN2 THERAPEUTICS INC ANTX | Almitas Capital LLC | 1,428,323 5.200% | 1,428,323 (New Position) | Filing History |
| 2025-06-18 11:08 am Sale | 2025-06-17 | 13D | AN2 THERAPEUTICS INC ANTX | BML Investment Partners L.P. | 427,432 1.400% | -2,789,991 (-86.72%) | Filing History |
| 2025-06-04 5:44 pm Purchase | 2025-05-28 | 13G | AN2 THERAPEUTICS INC ANTX | Coastlands Capital LP | 2,815,900 9.300% | 2,815,900 (New Position) | Filing History |
| 2025-05-30 5:46 pm Sale | 2025-05-28 | 13D | AN2 THERAPEUTICS INC ANTX | BML Investment Partners L.P. | 3,217,423 10.700% | -2,532,009 (-44.04%) | Filing History |
| 2025-05-07 10:27 am Unchanged | 2025-05-07 | 13D | AN2 THERAPEUTICS INC ANTX | BML Investment Partners L.P. | 5,749,432 19.100% | 0 (Unchanged) | Filing History |
| 2025-02-28 7:57 pm Sale | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | Adjuvant Global Health Technology Fund L.P. | 2,373,500 7.900% | -100,000 (-4.04%) | Filing History |
| 2025-02-14 6:27 pm Sale | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,999,997 (Position Closed) | Filing History |
| 2025-02-14 4:44 pm Sale | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | TCG Crossover GP I LLC | 0 0.000% | -1,555,118 (Position Closed) | Filing History |
| 2025-02-14 4:30 pm Sale | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | Brii Biosciences Ltd | 927,201 3.100% | -121,278 (-11.57%) | Filing History |
| 2025-02-14 11:07 am Sale | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | Frazier Life Sciences Public Fund L.P. | 0 0.000% | -1,488,889 (Position Closed) | Filing History |
| 2025-02-13 4:30 pm Purchase | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | Easom Eric | 1,893,132 6.200% | 320,962 (+20.42%) | Filing History |
| 2025-02-13 4:28 pm Unchanged | 2024-12-31 | 13G | AN2 THERAPEUTICS INC ANTX | BML Investment Partners L.P. | 5,749,432 19.200% | 0 (Unchanged) | Filing History |
| 2024-11-14 4:29 pm Sale | 2024-09-30 | 13G | AN2 THERAPEUTICS INC ANTX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -1,563,963 (Position Closed) | Filing History |
| 2024-11-14 4:16 pm Sale | 2024-09-30 | 13G | AN2 THERAPEUTICS INC ANTX | CITADEL ADVISORS LLC | 22 0.000% | -1,556,820 (-100.00%) | Filing History |
| 2024-11-13 4:25 pm Sale | 2024-09-30 | 13G | AN2 THERAPEUTICS INC ANTX | TCG Crossover GP I LLC | 1,555,118 5.200% | -1,123,091 (-41.93%) | Filing History |